This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
2C-B-FLY: Difference between revisions
>Joop m Added legal information for The Netherlands |
>Discount Pharmacologist |
||
| Line 27: | Line 27: | ||
==Pharmacology== | ==Pharmacology== | ||
{{Further|Serotonergic psychedelic}} | {{Further|Serotonergic psychedelic}} | ||
2C-B-FLY is a psychedelic phenethylamine, and is the dihydrodifuran analog of 2C-B. | |||
However, the role of these interactions and how they result in the psychedelic experience remains subject to on-going scientific investigation. | Little is known about how the totality of its effects are produced, 2C-B-FLY's [[psychedelic]] effects are believed to come from its efficacy at the [[Serotonin#The 5-HT system|5-HT<sub>2A</sub> receptor]] as a [[Agonist#Agonists|partial agonist]]. However, the role of these interactions and how they result in the psychedelic experience remains subject to on-going scientific investigation. | ||
==Subjective effects== | ==Subjective effects== | ||
| Line 128: | Line 128: | ||
===Experience reports=== | ===Experience reports=== | ||
There are currently no anecdotal reports which describe the effects of this compound within our [[experience index]]. Additional experience reports can be found here: | There are currently no anecdotal reports which describe the effects of this compound within our [[experience index]]. Additional experience reports can be found here: | ||
* [https://www.erowid.org/experiences/subs/exp_2CBFly.shtml Erowid Experience Vaults: 2C-B-FLY] | |||
*[https://www.erowid.org/experiences/subs/exp_2CBFly.shtml Erowid Experience Vaults: 2C-B-FLY] | |||
==Toxicity and harm potential== | ==Toxicity and harm potential== | ||
| Line 150: | Line 151: | ||
{| | {| | ||
|- | |- | ||
| | | | ||
*'''[[5-MeO-MiPT]]''' | *'''[[5-MeO-MiPT]]''' | ||
*'''[[2-C-T-7]]''' | *'''[[2-C-T-7]]''' | ||
| Line 178: | Line 179: | ||
*'''[[NM-2-AI]]''' | *'''[[NM-2-AI]]''' | ||
*'''[[Noopept]]''' | *'''[[Noopept]]''' | ||
*'''[[SSRIs]] | *'''[[SSRIs]]''' | ||
*'''[[SNRIs]] | *'''[[SNRIs]]''' | ||
|} | |} | ||
==Legal status== | ==Legal status== | ||
{{legalStub}} | {{legalStub}} | ||
*'''Austria''': 2C-B-FLY is illegal to possess, produce and sell under the NPSG. (Neue-Psychoaktive-Substanzen-Gesetz Österreich). | *'''Austria''': 2C-B-FLY is illegal to possess, produce and sell under the NPSG. (Neue-Psychoaktive-Substanzen-Gesetz Österreich). | ||
*'''Canada''': 2C-B-FLY would be considered Schedule III as it is a derivative of 2,5-dimethoxyphenethylamine.<ref>Controlled Drugs and Substances Act (S.C. 1996, c. 19) |http://laws-lois.justice.gc.ca/eng/acts/C-38.8/page-12.html#h-28</ref> | *'''Canada''': 2C-B-FLY would be considered Schedule III as it is a derivative of 2,5-dimethoxyphenethylamine.<ref>Controlled Drugs and Substances Act (S.C. 1996, c. 19) |http://laws-lois.justice.gc.ca/eng/acts/C-38.8/page-12.html#h-28</ref> | ||
| Line 195: | Line 197: | ||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
*[[Psychedelic]] | *[[Psychedelic]] | ||
| Line 203: | Line 206: | ||
==External links== | ==External links== | ||
*[https://en.wikipedia.org/wiki/2C-B-FLY 2C-B-FLY (Wikipedia)] | *[https://en.wikipedia.org/wiki/2C-B-FLY 2C-B-FLY (Wikipedia)] | ||
*[https://erowid.org/chemicals/2cb_fly/2cb_fly.shtml 2C-B-FLY (Erowid Vault)] | *[https://erowid.org/chemicals/2cb_fly/2cb_fly.shtml 2C-B-FLY (Erowid Vault)] | ||
*[https://isomerdesign.com/PiHKAL/explore.php?id=2021 2C-B-FLY (Isomer Design)] | *[https://isomerdesign.com/PiHKAL/explore.php?id=2021 2C-B-FLY (Isomer Design)] | ||
===Discussion=== | ===Discussion=== | ||
*[http://www.bluelight.org/vb/threads/225385-The-Big-amp-Dandy-2C-B-FLY-Thread The Big & Dandy 2C-B-Fly Thread (Bluelight)] | *[http://www.bluelight.org/vb/threads/225385-The-Big-amp-Dandy-2C-B-FLY-Thread The Big & Dandy 2C-B-Fly Thread (Bluelight)] | ||
==Literature== | ==Literature== | ||
* Greene, S. L. (2013). Benzofurans and benzodifurans. In Novel Psychoactive Substances (pp. 383-392). https://doi.org/10.1016/B978-0-12-415816-0.00016-X | |||
*Greene, S. L. (2013). Benzofurans and benzodifurans. In Novel Psychoactive Substances (pp. 383-392). https://doi.org/10.1016/B978-0-12-415816-0.00016-X | |||
==References== | ==References== | ||